Are plasma EBV DNA titers associated with outcomes for patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) receiving anti–programmed cell death 1 (anti–PD-1) monotherapy? Here, PDCD1 is linked to nasopharyngeal carcinoma.